Eikon Therapeutics Inc. Common Stock
EIKN | NASDAQ
$5.31
-$0.04 (-0.75%)
At close: Oct 30, 2026, 4:00 PM ET
$5.49
+$0.18 (+3.39%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Revenue | n/a |
Cost of Revenue | 24.18M |
Gross Profit | -24.18M |
Operating Income | -338.95M |
Interest Income | 15.57M |
Pretax Income | -324.25M |
Net Income | -324.25M |
Selling & General & Admin | 88.63M |
Research & Development | 250.32M |
Other Expenses | -24.18M |
Operating Expenses | 314.77M |
Interest Expense | 837K |
Selling & Marketing Expenses | n/a |
Cost & Expenses | 338.95M |
Income Tax Expense | n/a |
Shares Outstanding (Basic) | 54.14M |
Shares Outstanding (Diluted) | 54.14M |
EPS (Basic) | -6.16 |
EPS (Diluted) | -6.16 |
EBITDA | -299.24M |
EBIT | -323.41M |
Depreciation & Amortization | 24.18M |
Add to Watchlist
Select watchlists to add or remove EIKN